Compare BWXT & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWXT | ZBH |
|---|---|---|
| Founded | 1867 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 19.5B |
| IPO Year | 2010 | 2001 |
| Metric | BWXT | ZBH |
|---|---|---|
| Price | $209.64 | $89.31 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 19 |
| Target Price | ★ $208.23 | $105.17 |
| AVG Volume (30 Days) | 838.7K | ★ 1.9M |
| Earning Date | 05-26-2026 | 05-12-2026 |
| Dividend Yield | 0.52% | ★ 1.04% |
| EPS Growth | ★ 16.61 | N/A |
| EPS | ★ 3.58 | 3.55 |
| Revenue | $1,687,738,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $18.90 | $4.93 |
| Revenue Next Year | $10.10 | $3.72 |
| P/E Ratio | $58.09 | ★ $26.06 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $84.21 | $84.59 |
| 52 Week High | $220.57 | $114.44 |
| Indicator | BWXT | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 56.98 | 36.03 |
| Support Level | $202.50 | $85.23 |
| Resistance Level | $218.46 | $96.73 |
| Average True Range (ATR) | 8.57 | 2.68 |
| MACD | 0.55 | -0.87 |
| Stochastic Oscillator | 69.78 | 2.48 |
BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.